Skip Navigation


Carcinogenesis Advance Access originally published online on September 12, 2008
Carcinogenesis 2008 29(12):2267-2278; doi:10.1093/carcin/bgn216
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
29/12/2267    most recent
bgn216v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cannito, S.
Right arrow Articles by Parola, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cannito, S.
Right arrow Articles by Parola, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells

Stefania Cannito, Erica Novo, Alessandra Compagnone, Lorenzo Valfrè di Bonzo, Chiara Busletta, Elena Zamara, Claudia Paternostro, Davide Povero, Andrea Bandino, Francesca Bozzo, Carlo Cravanzola, Vittoria Bravoco, Sebastiano Colombatto and Maurizio Parola*

Dip. Medicina e Oncologia Sperimentale and Centro Interuniversitario di Fisiopatologia Epatica, University of Torino, Corso Raffaello 30, 10125 Torino, Italy

* To whom correspondence should be addressed. Tel: +39 011 6707772; Fax: +39 011 6707753; Email: maurizio.parola{at}unito.it

Epithelial–mesenchymal transition (EMT) and hypoxia are considered as crucial events favouring invasion and metastasis of many cancer cells. In this study, different human neoplastic cell lines of epithelial origin were exposed to hypoxic conditions in order to investigate whether hypoxia per se may trigger EMT programme as well as to mechanistically elucidate signal transduction mechanisms involved. The following human cancer cell lines were used: HepG2 (from human hepatoblastoma), PANC-1 (from pancreatic carcinoma), HT-29 (from colon carcinoma) and MCF-7 (from breast carcinoma). Cancer cells were exposed to carefully controlled hypoxic conditions and investigated for EMT changes and signal transduction by using morphological, cell and molecular biology techniques. All cancer cells responded to hypoxia within 72 h by classic EMT changes (fibroblastoid phenotype, SNAIL and β-catenin nuclear translocation and changes in E-cadherin) and by increased migration and invasiveness. This was involving very early inhibition of glycogen synthase kinase-3β (GSK-3β), early SNAIL translocation as well as later and long-lasting activation of Wnt/β-catenin-signalling machinery. Experimental manipulation, including silencing of hypoxia-inducible factor (HIF)-1{alpha} and the specific inhibition of mitochondrial generation of reactive oxygen species (ROS), revealed that early EMT-related events induced by hypoxia (GSK-3β inhibition and SNAIL translocation) were dependent on transient intracellular increased generation of ROS whereas late migration and invasiveness were sustained by HIF-1{alpha}- and vascular endothelial growth factor (VEGF)-dependent mechanisms. These findings indicate that in cancer cells, early redox mechanisms can switch on hypoxia-dependent EMT programme whereas increased invasiveness is sustained by late and HIF-1{alpha}-dependent release of VEGF.

Abbreviations: DPI, diphenyl-phenylene iodonium; EMT, epithelial–mesenchymal transition; Erk, extracellular signal-regulated kinase; GSK-3β, glycogen synthase kinase-3β; HIF, hypoxia-inducible factor; PI3-K, phosphatidylinositol 3-kinase; ROS, reactive oxygen species; Rot, Rotenone; siRNA, short interfering RNA; uPAR, urokinase-type plasminogen activator; VEGF, vascular endothelial growth factor

Received May 30, 2008; revised September 1, 2008; accepted September 6, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
K. J. Gordon, K. C. Kirkbride, T. How, and G. C. Blobe
Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2
Carcinogenesis, February 1, 2009; 30(2): 238 - 248.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.